<unk>  is a sub-field of genomics that characterizes cancer-associated genes. It focuses on genomic, epigenomic and transcript alterations in cancer. Cancer is a genetic disease caused by accumulation of DNA mutations and epigenetic alterations leading to unrestrained cell proliferation and neoplasm formation. The goal of<unk>  is to identify new oncogenes or tumor suppressor genes that may provide new insights into cancer diagnosis, predicting clinical outcome of cancers and new targets for cancer therapies. The success of targeted cancer therapies such as Gleevec, Herceptin and Avastin raised the hope for<unk>  to elucidate new targets for cancer treatment. Overall goals of<unk>  Besides understanding the underlying genetic mechanisms that initiate or drive cancer progression,<unk>  targets personalized cancer treatment. Cancer develops due to DNA mutations and epigenetic alterations that accumulate randomly. Identifying and targeting the mutations in an individual patient may lead to increased treatment efficacy. The completion of the Human Genome Project facilitated the field of<unk>  and increased the abilities of researchers to find oncogenes. Sequencing technologies and global methylation profiling techniques have been applied to the study of<unk> .
Oncogenomics
Molecular oncology
Lineage markers
Pharmacogenomics
Molecular medicine
Microstaging
Psychiatric genetics
Molecular tumor board